{
    "code": "60000965",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000965",
    "time": "2016-11-18 03:05:15",
    "許可證字號": "衛部菌疫輸字第000965號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/01\/20",
    "發證日期": "104\/01\/20",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000096504",
    "中文品名": "&quot;貝靈&quot;瑞利勁人體免疫球蛋白靜脈注射液10%",
    "英文品名": "Privigen",
    "適應症": "作為替代療法： \r\n1.原發性免疫不全症(Primary immunodeficiency syndromes, PID)如：\r\n(1)先天性丙種免疫球蛋白缺乏症(congenital agammaglobulinemia)及\r\n丙種免疫球蛋白過低症(hypogammaglobulinemia)\r\n(2)常見變異性免疫不全症(common variable immunodeficiency)\r\n(3)嚴重複合型免疫不全症(severe combined immunodeficiency)\r\n(4)Wiskott-Aldrich氏症候群 \r\n2.慢性淋巴性白血病引致丙種免疫球蛋白過低與復發性細菌感染者，\r\n且預防性抗生素治療無效的患者。 \r\n3.多發性骨髓瘤穩定期(plateau phase) 引致丙種免疫球蛋白過低與復\r\n發性細菌感染，且施打肺炎鏈球菌疫苗無效的患者。 \r\n4.異體造血幹細胞移植後引致丙種免疫球蛋白過低。 \r\n5.先天性愛滋病(AIDS)伴隨復發性細菌感染者。\r\n作為免疫調節：\r\n1.免疫性血小板缺乏紫斑症(Immune thrombocytopenic purpura, ITP)\r\n且具高出血風險或用於手術前矯正血小板計數。\r\n2.格林-巴利症候群(Guillain-Barre Syndrome)。\r\n3.川崎氏症(Kawasaki Disease)。\r\n4.慢性脫髓鞘多發性神經炎(Chronic inflammatory demyelinating\r\n polyneuropathy, CIDP)，對孩童的使用經驗有限。",
    "劑型": "27D注射液劑",
    "包裝": "100支以下盒裝 25、50、100、200毫升玻璃小瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "IMMUNOGLOBULINHUMAN"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0601501100  吉發企業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F430111100  CSL BEHRING AG",
        "製造廠廠址": "WANKDORFSTRASSE 10, 3014 BERN, SWITZERLAND",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "8004000603",
            "成分名稱": "IMMUNOGLOBULIN HUMAN",
            "含量描述": "Human plasma protein with at least 98% IgG",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Privigen 105.10.05仿單-105-10-05.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000965&Seq=004&Type=9"
        },
        {
            "title": "仿單：“貝靈”瑞利勁人體免疫球蛋白靜脈注射液(英文)-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000965&Seq=003&Type=9"
        },
        {
            "title": "Privigen仿單_Chinese-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000965&Seq=002&Type=9"
        },
        {
            "title": "100009650001-104-04-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000965&Seq=001&Type=9"
        },
        {
            "title": "Privigen 外盒標簽-105-10-05.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000965&Seq=003&Type=8"
        },
        {
            "title": "標籤外盒-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000965&Seq=002&Type=8"
        },
        {
            "title": "100009650002-104-04-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000965&Seq=001&Type=8"
        }
    ]
}